Literature DB >> 2248187

Peripheral arterial occlusive disease of the extremities in the United States: hospitalization and mortality.

R F Gillum1.   

Abstract

PAODE is an important cause of morbidity and health care expenditures among the elderly. Data from the NHDS and National Vital Statistics System were used to assess its impact in the U.S. In 1985 to 1987, an estimated 229 thousand men and 184 thousand women per year were discharged with any diagnosis of chronic PAODE. Discharge rates were much higher in men and increased sharply with age. Lower extremity arteriography was performed during 88 thousand hospitalizations and aorta-iliac-femoral bypass procedures were done during 31 thousand hospitalizations per year. Numbers of procedures increased markedly since 1979. An estimated 60 thousand men and 50 thousand women per year were discharged with any diagnosis of acute PAODE. Embolectomy or thrombectomy of lower limb arteries was listed for 28 thousand discharges per year. Few deaths were attributed to PAODE. Although these data are limited by likely incomplete reporting and by the nonspecificity of diagnostic codes, they provide an indication of the magnitude of the problem. An aging population and advances in surgical techniques suggest continued monitoring using multiple data sources. Vigorous primary prevention programs are needed to lessen the impact of all atherosclerotic diseases.

Entities:  

Mesh:

Year:  1990        PMID: 2248187     DOI: 10.1016/0002-8703(90)90257-x

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  8 in total

1.  An adamantanone derivative that is an original modulator of redox processes in the cytochrome P-450 system can serve as an effective remedy against obliterating angiopathy of lower extremities.

Authors:  I E Kovalev; V M Koshkin; N V Shipulina; E I Rumyantseva
Journal:  Dokl Biochem Biophys       Date:  2003 Jul-Aug       Impact factor: 0.788

Review 2.  Genetics of peripheral artery disease.

Authors:  Nicholas J Leeper; Iftikhar J Kullo; John P Cooke
Journal:  Circulation       Date:  2012-06-26       Impact factor: 29.690

3.  Intermittent claudication: pharmacoeconomic and quality-of-life aspects of treatment.

Authors:  Gregorio Brevetti; Roberta Annecchini; Roxanna Bucur
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 4.  A review of the role of anticoagulation in the treatment of peripheral arterial disease.

Authors:  Thomas F Whayne
Journal:  Int J Angiol       Date:  2012-12

5.  The relationship of renal function to segmental vascular stiffness, ankle-brachial index, and peripheral artery disease.

Authors:  Yueh-Hung Lin; Kuo-Tzu Sung; Cheng-Ting Tsai; Pei-Chen Wu; Yau-Huei Lai; Chi-In Lo; Fa-Chang Yu; Hsu-Ping Wu; Wei-Ran Lan; Jen-Yuan Kuo; Charles Jia-Yin Hou; Chi-Hsuan Yen; Ming-Cheng Peng; Ta-Chuan Hung; Chung-Lieh Hung; Edward Lai; Hung-I Yeh
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-05-11       Impact factor: 3.738

6.  Systematic review of pharmacological therapies for the management of ischaemic pain in patients with non-reconstructable critical limb ischaemia.

Authors:  Áine Ní Laoire; Fliss E M Murtagh
Journal:  BMJ Support Palliat Care       Date:  2017-08-23       Impact factor: 3.568

7.  Prevalence and risk factors of asymptomatic peripheral arterial disease in patients with COPD in Taiwan.

Authors:  Ming-Shian Lin; Kun-Yen Hsu; Yi-Jen Chen; Cheng-Ren Chen; Chuan-Mu Chen; Wei Chen
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

8.  Autologous bone-marrow mesenchymal stem cell implantation and endothelial function in a rabbit ischemic limb model.

Authors:  Shinsuke Mikami; Ayumu Nakashima; Keigo Nakagawa; Tatsuya Maruhashi; Yumiko Iwamoto; Masato Kajikawa; Takeshi Matsumoto; Yasuki Kihara; Kazuaki Chayama; Kensuke Noma; Mitsuo Ochi; Masahiro Nishimura; Koichiro Tsuji; Yukio Kato; Chikara Goto; Yukihito Higashi
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.